Cecilia Schott

Cecilia Schott

Company: Novartis AG

Job title: Vice President, Global Head Precision Diagnostics


Panel Discussion: Driving Widespread Adoption of Reproducible, Innovative & Clinically Validated LBx Tests to Improve Patient Access through Increased Reimbursements 9:30 am

What are the challenges faced in obtaining reimbursement for LBx tests? How to advise recommendations to improve reimbursement policies for LBx tests used in surveillance? What role does standardization, enhanced evidence generation, and ongoing communication/collaboration between stakeholders play in achieving reimbursements?Read more

day: Day Two

Patient Access to Liquid Biopsy Quality Testing 9:00 am

Painting a picture of the patients understanding of liquid biopsy Developing a robust infrastructure; where to get tested and who pays for it? Interpreting tests to ensure actionabilityRead more

day: Day Two

Chair’s Opening Remarks 8:20 am

Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.